Free Trial

Genpact (NYSE:G) Reaches New 52-Week High - What's Next?

Genpact logo with Business Services background

Genpact Limited (NYSE:G - Get Free Report)'s share price hit a new 52-week high during trading on Wednesday . The company traded as high as $48.14 and last traded at $47.64, with a volume of 117816 shares traded. The stock had previously closed at $47.64.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on G shares. Needham & Company LLC boosted their target price on Genpact from $42.00 to $55.00 and gave the company a "buy" rating in a research note on Monday, November 11th. TD Cowen boosted their target price on Genpact from $40.00 to $45.00 and gave the company a "hold" rating in a research note on Friday, November 8th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and lifted their price target for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, Robert W. Baird lifted their price target on Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a research report on Friday, November 8th. Seven analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $44.00.

Read Our Latest Stock Analysis on Genpact

Genpact Stock Performance

The company has a market cap of $8.39 billion, a PE ratio of 13.07, a PEG ratio of 1.51 and a beta of 1.18. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. The business has a 50-day moving average of $44.55 and a 200 day moving average of $40.51.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The business services provider reported $0.75 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.04. The business had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.19 billion. Genpact had a return on equity of 21.85% and a net margin of 14.22%. During the same quarter in the prior year, the business posted $0.67 earnings per share. Equities research analysts anticipate that Genpact Limited will post 2.94 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the transaction, the chief executive officer now directly owns 267,404 shares of the company's stock, valued at approximately $11,926,218.40. This represents a 4.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares of the company's stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 35,058 shares of company stock worth $1,558,675. 2.80% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Genpact

Several institutional investors have recently modified their holdings of the stock. UMB Bank n.a. raised its holdings in shares of Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after buying an additional 433 shares during the period. Venturi Wealth Management LLC raised its holdings in shares of Genpact by 74.6% in the third quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider's stock worth $103,000 after buying an additional 1,121 shares during the period. GAMMA Investing LLC raised its holdings in shares of Genpact by 221.3% in the third quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider's stock worth $131,000 after buying an additional 2,293 shares during the period. Versant Capital Management Inc raised its holdings in shares of Genpact by 17.0% in the fourth quarter. Versant Capital Management Inc now owns 3,178 shares of the business services provider's stock worth $136,000 after buying an additional 461 shares during the period. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in shares of Genpact by 22.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 3,378 shares of the business services provider's stock worth $145,000 after buying an additional 619 shares during the period. 96.03% of the stock is owned by institutional investors.

About Genpact

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash
NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines